Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Glucagon and Endogenous Glucose Production
NCT02740829Phase 1Completed
- Sponsor
- University Health Network
- Start
- Mar 2015
- Primary completion
- Jan 2016
01
Overview
Phase 1, randomised, single-blind trial of glucagon in diabetes mellitus (DM), sponsored by University Health Network. Primary endpoint: Endogenous glucose production at 6 hours. Started Mar 2015; status: completed.
02
Drugs
glucagon
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02740829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740829.